Search This Blog

Friday, February 2, 2024

Pfizer-Genmab: EU accepts application for cervical cancer

 

  • Validation is supported by data from Phase 3 innovaTV 301 trial

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)